Management of Central and Peripheral Nervous System Tumors in Patients with Neurofibromatosis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Management of Central and Peripheral Nervous System Tumors in Patients with Neurofibromatosis
Authors
Keywords
-
Journal
Current Oncology Reports
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-31
DOI
10.1007/s11912-023-01451-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Whole-body MRI evaluation in neurofibromatosis type 1 patients younger than 3 years old and the genetic contribution to disease progression
- (2022) Eungu Kang et al. Orphanet Journal of Rare Diseases
- Comparing Hearing Outcomes in Irradiated and Conservatively Managed Vestibular Schwannoma
- (2022) Omneya Ismail et al. OTOLOGY & NEUROTOLOGY
- Malignant Peripheral Nerve Sheath Tumors—A Comprehensive Review of Pathophysiology, Diagnosis, and Multidisciplinary Management
- (2022) Samantha W. E. Knight et al. Children-Basel
- ERN GENTURIS clinical practice guidelines for the diagnosis, treatment, management and surveillance of people with schwannomatosis
- (2022) D. Gareth Evans et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation
- (2022) Scott R. Plotkin et al. GENETICS IN MEDICINE
- Neurofibromatosis from Head to Toe: What the Radiologist Needs to Know
- (2022) Mindy X. Wang et al. RADIOGRAPHICS
- Efficacy and Safety of Trametinib in Neurofibromatosis Type 1-Associated Plexiform Neurofibroma and Low-Grade Glioma: A Systematic Review and Meta-Analysis
- (2022) Dun Wang et al. Pharmaceuticals
- Redefining germline predisposition in children with molecularly characterized ependymoma: a population-based 20-year cohort
- (2022) Jon Foss-Skiftesvik et al. Acta Neuropathologica Communications
- Current update on the visual outcome of optic pathway glioma associated with neurofibromatosis type-1
- (2022) Janice Lasky Zeid Frontiers in Surgery
- Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial
- (2021) Michael J. Fisher et al. NATURE MEDICINE
- Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1)
- (2021) Michael J. Fisher et al. ACTA NEUROPATHOLOGICA
- Systemic Options for Malignant Peripheral Nerve Sheath Tumors
- (2021) Ayesha Hassan et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- A Phase 2 Trial of Selumetinib in Children with Recurrent Optic Pathway and Hypothalamic Low-Grade Glioma without NF1: A Pediatric Brain Tumor Consortium Study
- (2021) Jason Fangusaro et al. NEURO-ONCOLOGY
- ABI-auditory brainstem implant
- (2021) Anandhan Dhanasingh et al. ACTA OTO-LARYNGOLOGICA
- Bevacizumab as a surgery-sparing agent for spinal ependymoma in patients with neurofibromatosis type II: Systematic review and case
- (2021) M. Harrison Snyder et al. JOURNAL OF CLINICAL NEUROSCIENCE
- A Phase I Study of the Combination of Pexidartinib and Sirolimus to Target Tumor-Associated Macrophages in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors
- (2021) Gulam A. Manji et al. CLINICAL CANCER RESEARCH
- Phase 0 Clinical Trial of Everolimus in Patients with Vestibular Schwannoma or Meningioma
- (2021) Matthias A. Karajannis et al. MOLECULAR CANCER THERAPEUTICS
- Early phase clinical studies of AR ‐42, a histone deacetylase inhibitor, for neurofibromatosis type 2‐associated vestibular schwannomas and meningiomas
- (2021) D. Bradley Welling et al. Laryngoscope Investigative Otolaryngology
- Clinical Outcomes and Prognostic Factors for Patients with Malignant Peripheral Nerve Sheath Tumour
- (2021) Yoshinori Imura et al. Sarcoma
- Metastatic Malignant Peripheral Nerve Sheath Tumor With NF1 Successfully Treated With ‘Gradual Subtraction’ ICE Chemotherapy
- (2020) YIQING WANG et al. ANTICANCER RESEARCH
- The emerging role of hearing loss rehabilitation in patients with vestibular schwannoma treated with Gamma Knife radiosurgery: literature review
- (2020) Carlotta Morselli et al. NEUROSURGICAL REVIEW
- The Use of MEK Inhibitors in Neurofibromatosis Type 1–Associated Tumors and Management of Toxicities
- (2020) Laura J. Klesse et al. ONCOLOGIST
- Phase II clinical trial of pazopanib for patients with unresectable or metastatic malignant peripheral nerve sheath tumors
- (2020) Yoshihiro Nishida et al. INTERNATIONAL JOURNAL OF CANCER
- ADVL1522: A phase 2 study of lorvotuzumab mertansine (IMGN901) in children with relapsed or refractory wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma, malignant peripheral nerve sheath tumor, or synovial sarcoma—A Children's Oncology Group study
- (2020) James I. Geller et al. CANCER
- Facial Nerve Outcomes After Vestibular Schwannoma Microsurgical Resection in Neurofibromatosis Type 2
- (2020) Catherine Sobieski et al. OTOLARYNGOLOGY-HEAD AND NECK SURGERY
- Prognosis and risk factors for malignant peripheral nerve sheath tumor: a systematic review and meta-analysis
- (2020) Zhenyu Cai et al. World Journal of Surgical Oncology
- Treatment Analysis and Overall Survival Outcomes of Patients With Bilateral Vestibular Schwannoma
- (2020) Khodayar Goshtasbi et al. OTOLOGY & NEUROTOLOGY
- Efficacy and Safety of Gamma Knife Radiosurgery for Meningiomas in Patients with Neurofibromatosis Type 2: A Long-Term Follow-Up Single-Center Study
- (2019) Faliang Gao et al. World Neurosurgery
- An update on the central nervous system manifestations of neurofibromatosis type 1
- (2019) J. Stephen Nix et al. ACTA NEUROPATHOLOGICA
- Trametinib Induces Neurofibroma Shrinkage and Enables Surgery
- (2019) Pia Vaassen et al. NEUROPEDIATRICS
- Incidence of mosaicism in 1055 de novo NF2 cases: much higher than previous estimates with high utility of next-generation sequencing
- (2019) D. Gareth Evans et al. GENETICS IN MEDICINE
- Efficacy and safety of bevacizumab for vestibular schwannoma in neurofibromatosis type 2: a systematic review and meta-analysis of treatment outcomes
- (2019) Victor M. Lu et al. JOURNAL OF NEURO-ONCOLOGY
- Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study
- (2019) D. Gareth R. Evans et al. GENETICS IN MEDICINE
- Radiation-induced and neurofibromatosis-associated malignant peripheral nerve sheath tumors (MPNST) have worse outcomes than sporadic MPNST
- (2019) Ruoyu Miao et al. RADIOTHERAPY AND ONCOLOGY
- Correction: Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study
- (2019) D. Gareth R. Evans et al. GENETICS IN MEDICINE
- Malignant Peripheral Nerve Sheath Tumors
- (2018) Andrew J. Bishop et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Phenotypic and genotypic overlap between mosaic NF2 and schwannomatosis in patients with multiple non-intradermal schwannomas
- (2018) Hildegard Kehrer-Sawatzki et al. HUMAN GENETICS
- A Systematic Review of Radiosurgery Versus Surgery for Neurofibromatosis Type 2 Vestibular Schwannomas
- (2018) Lawrance K. Chung et al. World Neurosurgery
- Long-Term Hearing Outcomes Following Stereotactic Radiosurgery in Vestibular Schwannoma Patients—A Retrospective Cohort Study
- (2018) Peter L Santa Maria et al. NEUROSURGERY
- A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath Tumors
- (2018) David R. D'Adamo et al. ONCOLOGIST
- Radiotherapy in Patients with Vestibular Schwannoma and Neurofibromatosis Type 2: Clinical Results and Review of the Literature
- (2018) Johanna Wagner et al. TUMORI
- Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1—a consensus overview
- (2017) Markku M. Miettinen et al. HUMAN PATHOLOGY
- A 4-year phase II study of everolimus in NF2 patients with growing vestibular schwannomas
- (2017) Stéphane Goutagny et al. JOURNAL OF NEURO-ONCOLOGY
- Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1–associated, and radiation-associated malignant peripheral nerve sheath tumors
- (2017) Kelsey L. Watson et al. JOURNAL OF NEUROSURGERY
- Malignant Peripheral Nerve Sheath Tumors are not a Feature of Neurofibromatosis Type 2 in the Unirradiated Patient
- (2017) Andrew T King et al. NEUROSURGERY
- Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: Implications for immunotherapy
- (2017) Kellie B. Haworth et al. Oncotarget
- Outcomes of Treatment for Malignant Peripheral Nerve Sheath Tumors: Different Clinical Features Associated with Neurofibromatosis Type 1
- (2017) In Kyung Hwang et al. Cancer Research and Treatment
- Loss of H3K27me3 Expression Is a Highly Sensitive Marker for Sporadic and Radiation-induced MPNST
- (2016) Carlos N. Prieto-Granada et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcoma
- (2016) M. A. Dickson et al. ANNALS OF ONCOLOGY
- Activity of Selumetinib in Neurofibromatosis Type 1–Related Plexiform Neurofibromas
- (2016) Eva Dombi et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcoma
- (2015) Scott M. Schuetze et al. CANCER
- PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors
- (2014) William Lee et al. NATURE GENETICS
- Intracranial meningiomas and neurofibromatosis type 2
- (2013) Rabih Aboukais et al. ACTA NEUROCHIRURGICA
- Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas
- (2013) Matthias A. Karajannis et al. NEURO-ONCOLOGY
- Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas—a Pediatric Brain Tumor Consortium study
- (2013) Sridharan Gururangan et al. NEURO-ONCOLOGY
- Phase II Study of Weekly Vinblastine in Recurrent or Refractory Pediatric Low-Grade Glioma
- (2012) Eric Bouffet et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas
- (2012) Matthias A. Karajannis et al. NEURO-ONCOLOGY
- Spinal ependymomas in neurofibromatosis Type 2: a retrospective analysis of 55 patients
- (2011) Scott R. Plotkin et al. JOURNAL OF NEUROSURGERY-SPINE
- Erlotinib for Progressive Vestibular Schwannoma in Neurofibromatosis 2 Patients
- (2010) Scott R. Plotkin et al. OTOLOGY & NEUROTOLOGY
- Phase II Multicenter Trial of Imatinib in 10 Histologic Subtypes of Sarcoma Using a Bayesian Hierarchical Statistical Model
- (2009) Rashmi Chugh et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas
- (2009) Robert G. Maki et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started